A single-peptide BPC-157 protocol starts at a 1-cycle level with 2- and 3-cycle options that bring the per-cycle cost down
Moll H, Frey E, Gerber P, Geidl B, Kaufmann M, Braun J, et al
DG exerts a protective effect in LPS-induced acute liver injury by activating the Nrf2/ARE pathway, enhancing the livers antioxidant capacity, and indirectly inhibiting inflammatory responses
The intricate link between metabolic dysregulation and immune dysfunction in ASD suggests that targeting cellular metabolism could offer novel therapeutic avenues
2025;337(Pt 3):118963
Recent studies have shown that the lncRNA 00312/miR-34a-5p/ASS1 axis reduces proliferation and invasion and promotes apoptosis in RCC (113), and that the SNHG12/SP1/CDCA3 ferroptosis-related long non-coding RNA (FRIncRNA) axis promotes RCC progression and sunitinib resistance, thereby serving as a new target for the treatment of sunitinib-resistant RCC (114)